Noctrix Health, Inc. clinical trials
Acquired by ResMed, Jun 1, 2026 · source ↗
The registry lists 9 studies whose lead sponsor is Noctrix Health, Inc.. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 30, 2026.
- 9studies on the registry
- 2open to participants now
- 2reach primary completion within a year
Before and after it joined ResMed
- First submitted before Noctrix Health, Inc. became part of ResMed
- 8
- First submitted after Noctrix Health, Inc. became part of ResMed
- 1
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Coming up
2 of Noctrix Health, Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- NNov ’26’26
- 1DDec
- 1JJan ’27’27
- FFeb
- MMar
- AApr
- MMay
- JJun
- JJul
- AAug
- SSep
- OOct
- NNov
All 2
Add all 2 to your calendar (.ics) → With an account.
All 9 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 19
- 20
- 321
- 22
- 23
- 24
- 25
- 226
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Noctrix Health, Inc.9 studies
Something wrong with this grouping? Tell us on the ResMed page.
Studies
Recruiting first, then most recently updated. Showing 9 of 9. All ResMed studies →
- Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)RecruitingNCT07675109Not applicable
Sponsor listed in the registry: Noctrix Health, Inc. · First submitted after Noctrix Health, Inc. became part of ResMed
- Tonic Motor Activation (TOMAC) Therapy in Patients With Restless Legs Syndrome and Dopaminergic AugmentationNot yet recruitingNCT07397247Not applicable
Sponsor listed in the registry: Noctrix Health, Inc. · First submitted before Noctrix Health, Inc. became part of ResMed
- A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLSActive, not recruitingNCT06076499
Sponsor listed in the registry: Noctrix Health, Inc. · First submitted before Noctrix Health, Inc. became part of ResMed
- Response to an Investigational Device in Patients With Restless Legs SyndromeActive, not recruitingNCT06866132Not applicable
Sponsor listed in the registry: Noctrix Health, Inc. · First submitted before Noctrix Health, Inc. became part of ResMed
- Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)CompletedNCT04874155Not applicable
Sponsor listed in the registry: Noctrix Health, Inc. · First submitted before Noctrix Health, Inc. became part of ResMed
- Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication ReductionCompletedNCT04698343Not applicable
Sponsor listed in the registry: Noctrix Health, Inc. · First submitted before Noctrix Health, Inc. became part of ResMed
- Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLSCompletedNCT05196828Not applicable
Sponsor listed in the registry: Noctrix Health, Inc. · First submitted before Noctrix Health, Inc. became part of ResMed
- Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLSCompletedNCT05214963Not applicable
Sponsor listed in the registry: Noctrix Health, Inc. · First submitted before Noctrix Health, Inc. became part of ResMed
- Noninvasive Peripheral Nerve Stimulation for Restless Legs SyndromeCompletedNCT04700683Not applicable
Sponsor listed in the registry: Noctrix Health, Inc. · First submitted before Noctrix Health, Inc. became part of ResMed